T1	Participants 0 57	QT/QTc study conducted in Japanese adult healthy subjects
T2	Participants 318 380	Forty-eight Japanese healthy subjects (males 24; females 24) r
T3	Participants 244 316	new xanthine oxidase inhibitor topiroxostat in Japanese healthy subjects
T4	Participants 1296 1331	QT/QTc studies in Japanese subjects
T5	Participants 1364 1416	QT-interval prolongation in males as well as females
